<p>Kesimpta is a medicine for treating adults with relapsing forms of multiple sclerosis (MS), where the patient has flare-ups (relapses) followed by periods with milder or no symptoms. It is used in patients with active disease, which means that they have relapses and/or signs of active inflammation on scans.</p><p>Kesimpta contains the active substance ofatumumab.</p>
Therapeutic Indication
<div class="subsection mt-3-5"> <h3>Therapeutic indication</h3><p>Kesimpta is indicated for the treatment of adult patients with relapsing forms of multiple sclerosis (RMS) with active disease defined by clinical or imaging features (see section 5.1).</p> </div>
Therapeutic Area (MeSH)
ATC Code
L04AA52
ATC Item
N/A
Pharmacotherapeutic Group
Immunosuppressant
Active Substance (Summary)
INN / Common Names
| Substance | CAS | Monograph |
|---|---|---|
| ofatumumab | N/A | ofatumumab |
EMA Name
Kesimpta
Medicine Name
Kesimpta
Aliases
N/ANo risk management plan link.
